Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 6
Submit an article Journal homepage
830
Views
6
CrossRef citations to date
0
Altmetric
Author's View

Regramming myeloid responses to improve cancer immunotherapy

Yu ZhuDepartment of Medicine; Washington University School of Medicine; St. Louis, MO, USA;Siteman Cancer Center; Washington University School of Medicine; St. Louis, MO, USA;ICCE Institute; Washington University School of Medicine; St. Louis, MO, USA
,
William G HawkinsSiteman Cancer Center; Washington University School of Medicine; St. Louis, MO, USA;Department of Surgery; Washington University School of Medicine; St. Louis, MO, USA
&
David G DeNardoDepartment of Medicine; Washington University School of Medicine; St. Louis, MO, USA;Siteman Cancer Center; Washington University School of Medicine; St. Louis, MO, USA;ICCE Institute; Washington University School of Medicine; St. Louis, MO, USA;Department of Pathology and Immunology; Washington University School of Medicine; St. Louis, MO, USACorrespondence[email protected]
Article: e974399 | Received 02 Oct 2014, Accepted 04 Oct 2014, Published online: 22 May 2015

References

  • Quezada SA, Peggs KS. Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer. Br J Cancer 2013; 108:1560-5; PMID:23511566; http://dx.doi.org/10.1038/bjc.2013.117
  • Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
  • Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008; 8:299-308; PMID:18354418; http://dx.doi.org/10.1038/nrc2355
  • Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010; 363:411-22; PMID:20818862; http://dx.doi.org/10.1056/NEJMoa1001294
  • Royal RE, Levy C, Turner K, Mathur A, Hughes M, Kammula US, Sherry RM, Topalian SL, Yang JC, Lowy I, et al. Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother 2010; 33:828-33; PMID:20842054; http://dx.doi.org/10.1097/CJI.0b013e3181eec14c
  • Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immuno 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506
  • Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j.cell.2010.03.014
  • Highfill SL, Cui Y, Giles AJ, Smith JP, Zhang H, Morse E, Kaplan RN, Mackall CL. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci Translat Med 2014; 6:237ra67; PMID:24848257; http://dx.doi.org/10.1126/scitransl-med.3007974
  • Zhu Y, Knolhoff BL, Meyer MA, Nywening TM, West BL, Luo J, Wang-Gillam A, Goedegebuure SP, Linehan DC, DeNardo DG. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res 2014; 74(18):5057-69; PMID:25085815; http://dx.doi.org/10.1158/0008-5472.CAN-13-3723
  • Mok S, Koya RC, Tsui C, Xu J, Robert L, Wu L, Graeber TG, West BL, Bollag G, Ribas A. Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer Res 2014; 74:153-61; PMID:24247719; http://dx.doi.org/10.1158/0008-5472.CAN-13-1816

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.